Home » Speakers – RWE, Market Access, Pricing & Reimbursement

13th RWE, MARKET ACCESS, PRICING & REIMBURSEMENT World Congress 2026 Europe

Powering Market Access Through Real-World Evidence, Digital Innovation & Value-Based Strategies

Thursday 3rd - Friday 4th September 2026 - Hilton London Kensington, London, UK

2026 Key Industry Expert Speakers

Antonella Cardone

CEO

Cancer Patients Europe

John Purdy

Global Access- Population Health Strategy Lead

Roche

Marta Contente

Sr Director, Pipeline Head of Immunology

GHEVO, TEVA

Meni Styliadou

VP Health Data Partnerships, Data Science Institute

Takeda

Funmi Oluwa

Head, Market Access & External Engagement, UK/Ireland

UCB

Sheela Upadhyaya

Board Trustee, Medics for Rare Disease

Founder, Rarely Ordinary

Pedro Borga

Director, Regional Market Access and Pricing

Amicus Therapeutics

Professor James Levine MD PhD

President

Fondation Ipsen

Nigel Nicholls

General Manager UK/Nordics & Baltics

Egetis Therapeutics

Robert Mitchell-Thain

Chief Executive Officer

PBC Foundation

Funmi Oluwa

Head, Market Access & External Engagement, UK/Ireland

UCB

Andi Orlowski

Director

NHS Health Economics Unit

Dr Ruth Jacob

Global Group Director, Respiratory & Immunology – Health Economics & Payer Evidence

AstraZeneca

Awaiting for Photo & Bio

Head, US/Global Pricing and Contracting

Regeneron

Robert Fairless

Vice President, Law and Compliance International

Incyte

Marion Bouillon-Pichault

Director Global Policy & Access, Intercon & APAC

Bristol Myers Squibb

Alireza Moayyeri

Senior Director, Digital Transformation Lead, Global Real World Evidence & Market Access

UCB Pharma

Dr Mohamed ElSayed

Associate Director, International Medical Evidence Delivery

AstraZeneca

Awaiting for Photo & Bio

Senior Representative

PDC-CRO

Awaiting for Photo & Bio

Senior Representative

Miltenyi Biomedicine GmbH

Scroll to Top